|
End-of-day quote
Taiwan S.E.
02/10/2026
|
5-day change | 1st Jan Change | ||
| 1,165.00 TWD | -0.43% |
|
+0.87% | +174.96% |
Company Valuation: PharmaEssentia Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 78,065 | 1,43,840 | 1,14,578 | 2,04,725 | 1,73,829 | 4,82,813 | - | - |
| Change | - | 84.26% | -20.34% | 78.68% | -15.09% | 177.75% | - | - |
| Enterprise Value (EV) 1 | 75,148 | 1,33,629 | 94,995 | 1,83,725 | 1,53,423 | 4,56,668 | 4,48,571 | 4,82,813 |
| Change | - | 77.82% | -28.91% | 93.4% | -16.49% | 197.65% | -1.77% | 7.63% |
| P/E | -27.1x | -98.6x | -179x | 69.3x | 34.6x | 43.1x | 27.1x | 19x |
| PBR | 19.1x | 11.2x | 4.79x | 7.45x | 5.46x | 10.6x | 8.4x | - |
| PEG | - | 1.8x | 3x | -0x | 0.5x | 0x | 0.5x | 0.4x |
| Capitalization / Revenue | 119x | 49.9x | 22.4x | 21x | 11.1x | 16.9x | 11.6x | 8.32x |
| EV / Revenue | 114x | 46.4x | 18.6x | 18.9x | 9.81x | 16x | 10.8x | 8.32x |
| EV / EBITDA | -29x | -74.2x | -57.8x | 87.3x | 28.8x | 32.8x | 21.7x | 15.6x |
| EV / EBIT | -26.6x | -65.9x | -49.6x | 106x | 31.1x | 35.3x | 22.2x | 15.8x |
| EV / FCF | -29.7x | -73.5x | -49.8x | 102x | 41.7x | 64.8x | 43.9x | - |
| FCF Yield | -3.37% | -1.36% | -2.01% | 0.98% | 2.4% | 1.54% | 2.28% | - |
| Dividend per Share 2 | - | - | - | 0.8936 | 1.352 | 4 | 2.35 | - |
| Rate of return | - | - | - | 0.18% | 0.32% | 0.34% | 0.2% | - |
| EPS 2 | -8.773 | -3.932 | -1.568 | 7.214 | 12.25 | 27.03 | 43.02 | 61.25 |
| Distribution rate | - | - | - | 12.4% | 11% | 14.8% | 5.46% | - |
| Net sales 1 | 656.5 | 2,882 | 5,106 | 9,735 | 15,635 | 28,585 | 41,511 | 58,043 |
| EBITDA 1 | -2,595 | -1,800 | -1,645 | 2,104 | 5,327 | 13,907 | 20,650 | 30,942 |
| EBIT 1 | -2,822 | -2,028 | -1,913 | 1,736 | 4,928 | 12,946 | 20,244 | 30,594 |
| Net income 1 | -2,811 | -1,375 | -623.8 | 2,966 | 5,045 | 10,927 | 18,250 | 25,880 |
| Net Debt 1 | -2,917 | -10,211 | -19,582 | -21,000 | -20,406 | -26,145 | -34,242 | - |
| Reference price 2 | 238.02 | 387.49 | 281.07 | 499.59 | 423.70 | 1,165.00 | 1,165.00 | 1,165.00 |
| Nbr of stocks (in thousands) | 3,27,980 | 3,71,210 | 4,07,644 | 4,09,783 | 4,10,264 | 4,14,432 | - | - |
| Announcement Date | 02/03/22 | 01/03/23 | 27/02/24 | 26/02/25 | 03/03/26 | - | - | - |
1TWD in Million2TWD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 43.11x | 15.98x | 32.84x | 0.34% | 1.52TCr | |
| 21.73x | 7.71x | 15.48x | 1.37% | 7.42TCr | |
| 29.82x | 8.57x | 26.7x | 0.04% | 5.74TCr | |
| 32.98x | 5.93x | 17.77x | 0.98% | 4.76TCr | |
| -21.31x | 230.81x | -22.97x | -.--% | 4.43TCr | |
| 33.26x | 3.23x | 13.97x | -.--% | 4.25TCr | |
| 46.77x | 5.41x | 29.66x | -.--% | 4.07TCr | |
| 27.63x | 7.93x | 20.48x | 0.41% | 3.1TCr | |
| 32.99x | 7.05x | 18.3x | -.--% | 2.85TCr | |
| -15.1x | 5.68x | -7.14x | -.--% | 2.43TCr | |
| Average | 23.19x | 29.83x | 14.51x | 0.31% | 4.06TCr | |
| Weighted average by Cap. | 23.05x | 31.44x | 14.27x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 6446 Stock
- Valuation PharmaEssentia Corporation
Select your edition
All financial news and data tailored to specific country editions
